- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular-Based and Alternative Therapies for Pancreatic Cancer
Authors
Keywords
-
Journal
CANCER JOURNAL
Volume 18, Issue 6, Pages 665-673
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2012-11-27
DOI
10.1097/ppo.0b013e3182793ff6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HuR’s post-transcriptional regulation of death receptor 5 in pancreatic cancer cells
- (2012) Danielle M. Pineda et al. CANCER BIOLOGY & THERAPY
- Radiosensitization effect of poly(ADP-ribose) polymerase inhibition in cells exposed to low and high liner energy transfer radiation
- (2012) Takahisa Hirai et al. CANCER SCIENCE
- Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment
- (2012) Feng Yang et al. CANCER TREATMENT REVIEWS
- Conceptual Framework for Cutting the Pancreatic Cancer Fuel Supply
- (2012) A. Le et al. CLINICAL CANCER RESEARCH
- Genetic Basis of Pancreas Cancer Development and Progression: Insights from Whole-Exome and Whole-Genome Sequencing
- (2012) C. A. Iacobuzio-Donahue et al. CLINICAL CANCER RESEARCH
- Heterogeneity and Targeting of Pancreatic Cancer Stem Cells
- (2012) V. R. Penchev et al. CLINICAL CANCER RESEARCH
- The Pancreas Cancer Microenvironment
- (2012) C. Feig et al. CLINICAL CANCER RESEARCH
- Translational Therapeutic Opportunities in Ductal Adenocarcinoma of the Pancreas
- (2012) M. Hidalgo et al. CLINICAL CANCER RESEARCH
- NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
- (2012) Roger Stupp et al. EUROPEAN JOURNAL OF CANCER
- Rapid Generation of MicroRNA Sponges for MicroRNA Inhibition
- (2012) Joost Kluiver et al. PLoS One
- A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers
- (2012) Jordan M. Winter et al. PLoS One
- Distinct Genes Related to Drug Response Identified in ER Positive and ER Negative Breast Cancer Cell Lines
- (2012) Kui Shen et al. PLoS One
- A Lethally Irradiated Allogeneic Granulocyte-Macrophage Colony Stimulating Factor-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma
- (2011) Lutz Eric et al. ANNALS OF SURGERY
- Significance of combination therapy of zoledronic acid and gemcitabine on pancreatic cancer
- (2011) Ming Zhao et al. CANCER SCIENCE
- StellaTUM: current consensus and discussion on pancreatic stellate cell research
- (2011) Mert Erkan et al. GUT
- Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
- (2011) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- An Emerging Entity: Pancreatic Adenocarcinoma Associated with a Known BRCA Mutation: Clinical Descriptors, Treatment Implications, and Future Directions
- (2011) M. A. Lowery et al. ONCOLOGIST
- Hedgehog Signaling Antagonist GDC-0449 (Vismodegib) Inhibits Pancreatic Cancer Stem Cell Characteristics: Molecular Mechanisms
- (2011) Brahma N. Singh et al. PLoS One
- High-Intensity Focused Ultrasound Ablation: Effective and Safe Therapy for Solid Tumors in Difficult Locations
- (2010) Franco Orsi et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Concurrent gemcitabine and high-intensity focused ultrasound therapy in patients with locally advanced pancreatic cancer
- (2010) Hong Zhao et al. ANTI-CANCER DRUGS
- Nanoparticulate delivery of diphtheria toxin DNA effectively kills mesothelin expressing pancreatic cancer cells
- (2010) SL Showalter et al. CANCER BIOLOGY & THERAPY
- Noninvasive Radiofrequency Field Destruction of Pancreatic Adenocarcinoma Xenografts Treated with Targeted Gold Nanoparticles
- (2010) E. S. Glazer et al. CLINICAL CANCER RESEARCH
- Sensitivity to Poly(ADP-ribose) Polymerase (PARP) Inhibition Identifies Ubiquitin-specific Peptidase 11 (USP11) as a Regulator of DNA Double-strand Break Repair
- (2010) Timothy D. Wiltshire et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition
- (2010) L D Roy et al. ONCOGENE
- Inhibition of Pancreatic Stellate Cell Activation by Halofuginone Prevents Pancreatic Xenograft Tumor Development
- (2010) Itai Spector et al. PANCREAS
- The Role of HuR in Gemcitabine Efficacy in Pancreatic Cancer: HuR Up-regulates the Expression of the Gemcitabine Metabolizing Enzyme Deoxycytidine Kinase
- (2009) C. L. Costantino et al. CANCER RESEARCH
- Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells
- (2009) Y. Li et al. CANCER RESEARCH
- Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis
- (2009) Laetitia Devy et al. CANCER RESEARCH
- let-7 MicroRNA Transfer in Pancreatic Cancer-Derived Cells Inhibits In Vitro Cell Proliferation but Fails to Alter Tumor Progression
- (2009) Jérôme Torrisani et al. HUMAN GENE THERAPY
- The Immunoregulatory Enzyme IDO Paradoxically Drives B Cell-Mediated Autoimmunity
- (2009) G. N. Scott et al. JOURNAL OF IMMUNOLOGY
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antisense Inhibition of microRNA-21 or -221 Arrests Cell Cycle, Induces Apoptosis, and Sensitizes the Effects of Gemcitabine in Pancreatic Adenocarcinoma
- (2009) Jong-Kook Park et al. PANCREAS
- MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
- (2009) Qing Ji et al. PLoS One
- Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis
- (2009) Y.-H. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of Pancreatic Carcinoma Growth by Adenovirus-Mediated Human Interleukin-24 Expression in Animal Model
- (2008) Xinting Pan et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Pancreatic Stellate Cells: Partners in Crime with Pancreatic Cancer Cells
- (2008) A. Vonlaufen et al. CANCER RESEARCH
- Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent
- (2008) C. R. Patra et al. CANCER RESEARCH
- Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape
- (2008) Jessica B. Katz et al. IMMUNOLOGICAL REVIEWS
- BRCAGermline Mutations in Jewish Patients With Pancreatic Adenocarcinoma
- (2008) Cristina R. Ferrone et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search